Abstract: Systems and methods to validate RFID counts may be provided. A business may affix temporary or permanent location tags with barcodes throughout an area to be counted, and the location tags may then be recorded. Manual counters may perform a piece count of items associated with each location tag. RFID counters may perform an RFID read of items associated with each location tag. All RFID reads may be associated with their most likely location tag. The manual piece count may be compared to the total of RFID tags assigned to each location tag. Locations may be rejected where the totals do not match. Locations rejected by the manual piece count comparison may then be barcode scanned and compared to the RFID reads for each location tag required to be barcode scanned. Resolution may be performed for locations where the barcode item counts do not match the RFID item counts.

Abstract: Systems and methods to validate RFID counts may be provided. A business may affix temporary or permanent location tags with barcodes throughout an area to be counted, and the location tags may then be recorded. Manual counters may perform a piece count of items associated with each location tag. RFID counters may perform an RFID read of items associated with each location tag. All RFID reads may be associated with their most likely location tag. The manual piece count may be compared to the total of RFID tags assigned to each location tag. Locations may be rejected where the totals do not match. Locations rejected by the manual piece count comparison may then be barcode scanned and compared to the RFID reads for each location tag required to be barcode scanned. Resolution may be performed for locations where the barcode item counts do not match the RFID item counts.

Abstract: Compound of formula (I) wherein A is selected from pyridin-2-yl or thiazol-2-yl and R1, R2 and R3 are as described in the specification and their use in the treatment or prevention of a disease or medical conditions mediated through glucokinase.